Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Plehn

Showing results (181-190 of 196) with videos related to

Pageof 20
Sort By:
Journal of Medical Case Reports|November 18, 2009
Primary malignant pericardial mesothelioma - a rare cause of pericardial effusion and consecutive constrictive pericarditis: a case reportThomas Butz, Lothar Faber, Christoph Langer, et al.
The American Journal of Cardiology|February 22, 2005
Impact of nonfatal myocardial infarction on outcomes in patients with advanced heart failure and the effect of bucindolol therapyChristopher M O'Connor, Steven Gottlieb, Jamieson M Bourque, et al.
Journal of the American College of Cardiology|April 6, 2005
Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST)Paul A Grayburn, Christopher P Appleton, Anthony N DeMaria, et al.
American Heart Journal|October 12, 2010
Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST])Peter Carson, Mona Fiuzat, Christopher O'Connor, et al.
Circulation|November 5, 2003
Myocardial contractile reserve by dobutamine stress echocardiography predicts improvement in ejection fraction with beta-blockade in patients with heart failure: the Beta-Blocker Evaluation of Survival Trial (BEST)Eric J Eichhorn, Paul A Grayburn, Susan A Mayer, et al.
Circulation|August 1, 1993
Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET)B M Massie, M R Berk, S C Brozena, et al.
Stroke|August 28, 2010
Correlation of echocardiographic findings with cerebral infarction in elderly adults: the AGES-Reykjavik studyDorothea McAreavey, Jean-Sébastien Vidal, Thor Aspelund, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Concentrations of lysosomal cysteine proteases are decreased in renal cell carcinoma compared with normal kidneyH Kirschke, T Clausen, B Göhring, et al.
Circulation|January 20, 1999
Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care InvestigatorsJ F Plehn, B R Davis, F M Sacks, et al.
Arthritis and Rheumatism|August 1, 2008
A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndromeRaphaela Goldbach-Mansky, Sharukh D Shroff, Mildred Wilson, et al.
Pageof 20

Showing results (181-190 of 196) with videos related to

Sort By:
Pageof 20
Journal of Medical Case Reports|November 18, 2009
Primary malignant pericardial mesothelioma - a rare cause of pericardial effusion and consecutive constrictive pericarditis: a case reportThomas Butz, Lothar Faber, Christoph Langer, et al.
The American Journal of Cardiology|February 22, 2005
Impact of nonfatal myocardial infarction on outcomes in patients with advanced heart failure and the effect of bucindolol therapyChristopher M O'Connor, Steven Gottlieb, Jamieson M Bourque, et al.
Journal of the American College of Cardiology|April 6, 2005
Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST)Paul A Grayburn, Christopher P Appleton, Anthony N DeMaria, et al.
American Heart Journal|October 12, 2010
Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST])Peter Carson, Mona Fiuzat, Christopher O'Connor, et al.
Circulation|November 5, 2003
Myocardial contractile reserve by dobutamine stress echocardiography predicts improvement in ejection fraction with beta-blockade in patients with heart failure: the Beta-Blocker Evaluation of Survival Trial (BEST)Eric J Eichhorn, Paul A Grayburn, Susan A Mayer, et al.
Circulation|August 1, 1993
Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET)B M Massie, M R Berk, S C Brozena, et al.
Stroke|August 28, 2010
Correlation of echocardiographic findings with cerebral infarction in elderly adults: the AGES-Reykjavik studyDorothea McAreavey, Jean-Sébastien Vidal, Thor Aspelund, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Concentrations of lysosomal cysteine proteases are decreased in renal cell carcinoma compared with normal kidneyH Kirschke, T Clausen, B Göhring, et al.
Circulation|January 20, 1999
Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care InvestigatorsJ F Plehn, B R Davis, F M Sacks, et al.
Arthritis and Rheumatism|August 1, 2008
A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndromeRaphaela Goldbach-Mansky, Sharukh D Shroff, Mildred Wilson, et al.
Pageof 20